Nautilus Biotechnology Statistics
Total Valuation
NAUT has a market cap or net worth of $327.80 million. The enterprise value is $254.41 million.
Important Dates
The next confirmed earnings date is Tuesday, April 28, 2026, before market open.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NAUT has 126.56 million shares outstanding. The number of shares has increased by 0.66% in one year.
| Current Share Class | 126.56M |
| Shares Outstanding | 126.56M |
| Shares Change (YoY) | +0.66% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 32.91% |
| Owned by Institutions (%) | 15.35% |
| Float | 46.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.07 |
| P/TBV Ratio | 2.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.33, with a Debt / Equity ratio of 0.19.
| Current Ratio | 13.33 |
| Quick Ratio | 13.00 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -32.27% and return on invested capital (ROIC) is -19.60%.
| Return on Equity (ROE) | -32.27% |
| Return on Assets (ROA) | -19.26% |
| Return on Invested Capital (ROIC) | -19.60% |
| Return on Capital Employed (ROCE) | -36.49% |
| Weighted Average Cost of Capital (WACC) | 8.88% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$453,854 |
| Employee Count | 130 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +276.24% in the last 52 weeks. The beta is 0.99, so NAUT's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | +276.24% |
| 50-Day Moving Average | 2.90 |
| 200-Day Moving Average | 1.76 |
| Relative Strength Index (RSI) | 40.04 |
| Average Volume (20 Days) | 314,333 |
Short Selling Information
The latest short interest is 638,943, so 0.50% of the outstanding shares have been sold short.
| Short Interest | 638,943 |
| Short Previous Month | 674,952 |
| Short % of Shares Out | 0.50% |
| Short % of Float | 1.39% |
| Short Ratio (days to cover) | 1.51 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -66.84M |
| Pretax Income | -59.00M |
| Net Income | -59.00M |
| EBITDA | -65.08M |
| EBIT | -66.84M |
| Earnings Per Share (EPS) | -$0.47 |
Full Income StatementBalance Sheet
The company has $103.41 million in cash and $30.02 million in debt, giving a net cash position of $73.39 million or $0.58 per share.
| Cash & Cash Equivalents | 103.41M |
| Total Debt | 30.02M |
| Net Cash | 73.39M |
| Net Cash Per Share | $0.58 |
| Equity (Book Value) | 156.97M |
| Book Value Per Share | 1.24 |
| Working Capital | 98.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$50.70 million and capital expenditures -$1.28 million, giving a free cash flow of -$51.97 million.
| Operating Cash Flow | -50.70M |
| Capital Expenditures | -1.28M |
| Depreciation & Amortization | 1.75M |
| Net Borrowing | n/a |
| Free Cash Flow | -51.97M |
| FCF Per Share | -$0.41 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |